Company news

Tenaya Therapeutics, Inc. news in 2024

Tenaya Therapeutics, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Tenaya Therapeutics Reports Promising Early Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy

December 16, 2024

Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024

December 15, 2024

Tenaya Therapeutics Doses First Patient in RIDGE™-1 Phase 1b Clinical Trial of TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

November 24, 2024

Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

November 5, 2024

Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM

October 16, 2024

Tenaya Therapeutics to Participate in Upcoming Investment Conferences

September 2, 2024

Tenaya Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

August 7, 2024

Tenaya Therapeutics Announces Research Leadership Updates

June 26, 2024

Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit

June 17, 2024

Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

May 13, 2024

Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting

May 1, 2024

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

March 17, 2024

Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine

March 17, 2024

Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications

February 25, 2024

Tenaya Therapeutics Announces Pricing of Underwritten Offering

February 7, 2024

Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

January 2, 2024

Decks in 2024